Skip to content

Clinical trials

Phase 3 Premature Birth trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Premature Birth Phase: Phase 3 Country / region: United States Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20033
20042
20054
20061
20072
20083
20091
20103
20111
20121
20131
20141
20151
20163
20173
20191
20211
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Terminated9
Active, not recruiting2
Not yet recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NICHD Neonatal Research Network13
The George Washington University Biostatistics Center9
GlaxoSmithKline2
ONY2
Roberta Ballard2
Yale University2
AMAG Pharmaceuticals, Inc.1
American SIDS Institute1
Elgan Pharma Ltd.1
Fetal Medicine Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Premature Birth48
Respiratory Distress Syndrome10
Bronchopulmonary Dysplasia9
Infant, Newborn, Diseases3
Respiratory Insufficiency3
Ductus Arteriosus, Patent2
Hyperphagia2
Hypoxia2
Leukomalacia, Periventricular2
Malnutrition2

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.